Mdp Rotop (Medronic Acid)

Medronic Acid belongs to the bisphosphonate class. After intravenous injection it binds tightly to hydroxyapatite in bone, especially at sites of active remodeling. When labeled with a radioactive isotope, the compound emits gamma rays that can be detected by a gamma camera, producing images of bone metabolism.

The dose of Mdp Rotop is determined by the prescribing physician or nuclear medicine specialist based on the specific imaging protocol, patient weight, and the radiolabel used. No fixed public dosing regimen is provided; the healthcare professional sets the appropriate amount.

Mdp Rotop is generally contraindicated in pregnancy because the radiopharmaceutical exposes the fetus to ionizing radiation. Breastfeeding mothers should discontinue nursing for a period recommended by the treating physician, as the drug may be secreted in breast milk.

To order Mdp Rotop, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Mdp Rotop (Medronic Acid) is a first‑generation bisphosphonate tracer commonly used for bone scans. Compared with newer agents such as 99mTc‑HDP, it has similar bone affinity but may show slightly lower image resolution. Choice of agent depends on local practice, availability, and specific diagnostic requirements.

Mdp Rotop must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Prior to use, allow the vial to reach room temperature if required by the imaging protocol, and handle with aseptic technique to maintain sterility.

Mdp Rotop is administered by slow intravenous injection under the supervision of a qualified healthcare professional. After injection, a waiting period (typically 2–4 hours) allows the tracer to localize in bone before imaging is performed with a gamma camera.

The most serious risks include anaphylactic or severe allergic reactions, renal toxicity in patients with pre‑existing kidney impairment, and rare radiation‑induced bone marrow suppression. Immediate medical attention is required if signs of anaphylaxis or sudden renal dysfunction appear.

Mdp Rotop should be avoided in patients with known hypersensitivity to bisphosphonates or radiopharmaceuticals, those with severe renal insufficiency, pregnant women, and individuals for whom the radiation exposure outweighs the diagnostic benefit.